Docetaxel

CAS 114977-28-5 28 FDA-DMF suppliersSmall Molecule

Overview

Docetaxel is a chemotherapy medication that works by interfering with cell division, used primarily in the treatment of breast, lung, prostate, and other cancers. It is a semi-synthetic analogue of paclitaxel and functions as a microtubule inhibitor.

API suppliers (23)

Suppliers of Docetaxel backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • SCINOPHARM TAIWAN LTD3 active DMF
  • INDENA SPAItaly2 active DMF
  • MSN Laboratories Private LimitedIndia2 active DMF
  • Qilu Pharmaceutical Co., Ltd.China1 active DMF
  • JIANGSU HENGRUI PHARMACEUTICALS CO LTDChina1 active DMF
  • Yifan Pharmaceutical Co., Ltd.China1 active DMF
  • BIOVECTRA INCCanada1 active DMF
  • BIOVECTRA INCCanada1 active DMF
  • TAPI NL BV1 active DMF
  • Laurus Labs LimitedIndia1 active DMF
  • Cycle Pharmaceuticals Ltd.United Kingdom1 active DMF
  • JIANGSU HENGRUI PHARMACEUTICALS CO LTDChina1 active DMF
  • FUJIAN KERUI PHARMACEUTICAL CO LTDChina1 active DMF
  • Intas Pharmaceuticals Ltd.India1 active DMF
  • MAC CHEM PRODUCTS INDIA PVT LTD
  • SAI PHYTOCEUTICALS PVT LTD
  • PTC Therapeutics, Inc.United States
  • Accord Healthcare LtdUnited Kingdom
  • FRESENIUS KABI ONCOLOGY LTD
  • ARCH PHARMALABS LTD
  • Zhejiang Hisun Pharmaceutical Co., Ltd.China
  • SAMYANG HOLDINGS CORP
  • Sichuan Baili Pharmaceutical Co., Ltd.China

Therapeutic areas

CancerBreast CancerProstate Cancer

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.